+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Osteoarthritis Therapeutics Market 2020-2024 - Product Image

Global Osteoarthritis Therapeutics Market 2020-2024

  • ID: 5019107
  • Report
  • April 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Global Osteoarthritis Therapeutics Market 2020-2024

The osteoarthritis therapeutics market is poised to grow by $ 2991.85 million during 2020-2024 progressing at a CAGR of 9% during the forecast period. The report on the osteoarthritis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of osteoarthritis and availability of improved diagnostic modalities. In addition, increasing incidence of osteoarthritis is anticipated to boost the growth of the market as well.

The osteoarthritis therapeutics market analysis includes product segment and geographic landscapes.

The osteoarthritis therapeutics market is segmented as below:

By Product
  • Analgesics and NSAIDs
  • Corticosteriods
  • Viscosupplements
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the availability of guidelines for disease management as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The osteoarthritis therapeutics market covers the following areas:
  • Osteoarthritis therapeutics market sizing
  • Osteoarthritis therapeutics market forecast
  • Osteoarthritis therapeutics market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading osteoarthritis therapeutics market vendors that include Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc.. Also, the osteoarthritis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Force Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Analgesics and NSAIDs - Market size and forecast 2019-2024
  • Corticosteriods - Market size and forecast 2019-2024
  • Viscosupplements - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product
Market Segmentation by Type
  • Ankle osteoarthritis
  • Hip osteoarthritis
  • Knee osteoarthritis
  • Shoulder osteoarthritis
  • Others
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Zimmer Biomet Holdings Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Product - Market share 2019-2024 (%)
22: Comparison by Product
23: Analgesics and NSAIDs - Market size and forecast 2019-2024 ($ million)
24: Analgesics and NSAIDs - Year-over-year growth 2019-2024 (%)
25: Corticosteriods - Market size and forecast 2019-2024 ($ million)
26: Corticosteriods - Year-over-year growth 2019-2024 (%)
27: Viscosupplements - Market size and forecast 2019-2024 ($ million)
28: Viscosupplements - Year-over-year growth 2019-2024 (%)
29: Others - Market size and forecast 2019-2024 ($ million)
30: Others - Year-over-year growth 2019-2024 (%)
31: Market opportunity by Product
32: Customer landscape
33: Market share by geography 2019-2024 (%)
34: Geographic comparison
35: North America - Market size and forecast 2019-2024 ($ million)
36: North America - Year-over-year growth 2019-2024 (%)
37: Europe - Market size and forecast 2019-2024 ($ million)
38: Europe - Year-over-year growth 2019-2024 (%)
39: Asia - Market size and forecast 2019-2024 ($ million)
40: Asia - Year-over-year growth 2019-2024 (%)
41: ROW - Market size and forecast 2019-2024 ($ million)
42: ROW - Year-over-year growth 2019-2024 (%)
43: Key leading countries
44: Market opportunity by geography ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: Abbott Laboratories - Overview
52: Abbott Laboratories - Business segments
53: Abbott Laboratories - Key offerings
54: Abbott Laboratories - Key customers
55: Abbott Laboratories - Segment focus
56: Anika Therapeutics Inc. - Overview
57: Anika Therapeutics Inc. - Business segments
58: Anika Therapeutics Inc. - Key offerings
59: Anika Therapeutics Inc. - Key customers
60: Anika Therapeutics Inc. - Segment focus
61: Bayer AG - Overview
62: Bayer AG - Business segments
63: Bayer AG - Key offerings
64: Bayer AG - Key customers
65: Bayer AG - Segment focus
66: F. Hoffmann-La Roche Ltd. - Overview
67: F. Hoffmann-La Roche Ltd. - Business segments
68: F. Hoffmann-La Roche Ltd. - Key offerings
69: F. Hoffmann-La Roche Ltd. - Key customers
70: F. Hoffmann-La Roche Ltd. - Segment focus
71: GlaxoSmithKline Plc - Overview
72: GlaxoSmithKline Plc - Business segments
73: GlaxoSmithKline Plc - Key offerings
74: GlaxoSmithKline Plc - Key customers
75: GlaxoSmithKline Plc - Segment focus
76: Johnson & Johnson - Overview
77: Johnson & Johnson - Business segments
78: Johnson & Johnson - Key offerings
79: Johnson & Johnson - Key customers
80: Johnson & Johnson - Segment focus
81: Novartis AG - Overview
82: Novartis AG - Business segments
83: Novartis AG - Key offerings
84: Novartis AG - Key customers
85: Novartis AG - Segment focus
86: Pfizer Inc. - Overview
87: Pfizer Inc. - Business segments
88: Pfizer Inc. - Key offerings
89: Pfizer Inc. - Key customers
90: Pfizer Inc. - Segment focus
91: Sanofi - Overview
92: Sanofi - Business segments
93: Sanofi - Key offerings
94: Sanofi - Key customers
95: Sanofi - Segment focus
96: Zimmer Biomet Holdings Inc. - Overview
97: Zimmer Biomet Holdings Inc. - Business segments
98: Zimmer Biomet Holdings Inc. - Key offerings
99: Zimmer Biomet Holdings Inc. - Key customers
100: Zimmer Biomet Holdings Inc. - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The research recognizes the following companies as the key players in the global osteoarthritis therapeutics market: Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the availability of guidelines for disease management ."

According to the report, one of the major drivers for this market is the increasing incidence of osteoarthritis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
Adroll
adroll